Mon, March 4, 2024
Fri, March 1, 2024
Thu, February 29, 2024

Brian Abrahams Maintained (XENE) at Buy with Decreased Target to $55 on, Mar 1st, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-55-on-mar-1st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Abrahams of RBC Capital, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Buy with Decreased Target from $56 to $55 on, Mar 1st, 2024.

Brian has made no other calls on XENE in the last 4 months.



There are 4 other peers that have a rating on XENE. Out of the 4 peers that are also analyzing XENE, 0 agree with Brian's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Brian


  • David Hoang of "Citigroup" Initiated at Strong Buy and Held Target at $62 on, Thursday, January 4th, 2024
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $56 on, Tuesday, January 2nd, 2024
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $62 on, Monday, December 18th, 2023
  • Brian Skorney of "Baird" Initiated at Buy and Held Target at $63 on, Friday, December 8th, 2023

Publication Contributing Sources